News
BIO
295.96
+1.28%
3.73
Weekly Report: what happened at BIO last week (0406-0410)?
Weekly Report · 2d ago
The Bull Case For Bio-Rad Laboratories (BIO) Could Change Following Citigroup’s Downgrade To Neutral
Simply Wall St · 04/08 23:25
A Look At Bio-Rad (BIO) Valuation After The Citi Downgrade And Price Target Cut
Simply Wall St · 04/07 19:15
Bio-Rad Laboratories Cut to Neutral From Buy by Citigroup
Dow Jones · 04/07 13:04
Bio-Rad Laboratories Price Target Cut to $300.00/Share From $375.00 by Citigroup
Dow Jones · 04/07 13:04
Citigroup Downgrades Bio-Rad Laboratories to Neutral, Lowers Price Target to $300
Benzinga · 04/07 12:55
Bio-Rad downgraded to Neutral from Buy at Citi
TipRanks · 04/07 09:40
Weekly Report: what happened at BIO last week (0330-0403)?
Weekly Report · 04/06 09:40
Weekly Report: what happened at BIO last week (0323-0327)?
Weekly Report · 03/30 09:40
Why Is Agilent (A) Down 6.2% Since Last Earnings Report?
NASDAQ · 03/27 15:30
Weekly Report: what happened at BIO last week (0316-0320)?
Weekly Report · 03/23 09:38
Weekly Report: what happened at BIO last week (0309-0313)?
Weekly Report · 03/16 09:38
Weekly Report: what happened at BIO last week (0302-0306)?
Weekly Report · 03/09 09:39
Assessing Bio-Rad (BIO) Valuation After Mixed Share Price Performance And Recurring Revenue Shift
Simply Wall St · 03/03 19:30
Weekly Report: what happened at BIO last week (0223-0227)?
Weekly Report · 03/02 09:39
Is It Time To Reconsider Bio-Rad Laboratories (BIO) After Its Prolonged Share Price Slump
Simply Wall St · 02/27 22:33
A Look At Bio Rad Laboratories (BIO) Valuation After Recent Share Price Weakness
Simply Wall St · 02/24 15:28
Weekly Report: what happened at BIO last week (0216-0220)?
Weekly Report · 02/23 09:38
Bio-Rad Updates Investors on Sartorius Strategic Investment Metrics
TipRanks · 02/19 22:20
Bio-Rad price target lowered to $320 from $340 at Wells Fargo
TipRanks · 02/16 12:45
More
Webull provides a variety of real-time BIO stock news. You can receive the latest news about Bio Rad Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.